Drug Database
Back to search

Belgium· BE-AMP-SAM467395-00

Reparil 20 mg

A vasoprotectives product containing escin, registered in Belgium by Impexeco. The same ATC class is registered in 2 of our 19 countries.

ATC C05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedReparil 20 mgATCC05REGISTER NO.BE-AMP-SAM467395-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about escinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Escin is registered in 2 of 19 countries.

Countries holding a registration under ATC C05 (vasoprotectives), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose
Search escin products by name

Escin · ATC C05

2 / 19 countries

  • Belgiumprice
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Escin
Manufacturer
Impexeco
Country
Belgium (BE)
ATC code
C05
ATC class
VASOPROTECTIVES
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3144185

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Escin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All escin products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Reparil, Venostasin
  • Bulgaria · Репарил
  • Czechia · Aescin Teva, Reparil Dragées
  • Germany · Reparil-Dragees, Reparil-Dragees Zur Anwendung Bei Erwachsenen Und Kindern Ab 7 Jahren
  • Italy · Edevexin, Reparilexin
  • Poland · Aescin
  • Slovakia · Aescin, Aescin Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/832b9f78-b6f9-4796-8eff-92bad0ff17e6
GET /v1/drugs/832b9f78-b6f9-4796-8eff-92bad0ff17e6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gastro-resistant tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Reparil 20 mg",
  "name_fr": "Reparil 20 mg",
  "name_nl": "Reparil 20 mg",
  "amp_code": "SAM467395-00",
  "strengths": [
    "20.0000",
    "20.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Escin",
    "Lactose",
    "Lactose Monohydrate",
    "Sodium Hydroxide",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Vasoprotectives",
  "authorisation_numbers": [
    "1549PI0200F003"
  ]
}
API referenceMCP serverPlans

See everything about escin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console